書籍情報から探す
Validity of Recommended Dosage Reduction Criteria for Rivaroxaban in Patients with Renal Impairment
Kazuhiro WATANABE1*, Yui TERASHI1, Kota ISHIDA2, Kazuko UEMATSU2, Iwao ENDO2, Kenshi SUZUKI2,3, Ichiro SUZUKI4, Kyoji TAGUCHI1*
1Educational and Research Center for Clinical Pharmacy, Showa Pharmaceutical University, 2Department of Pharmacy, Japanese Red Cross Medical Center, 3Department of Hematology, Japanese Red Cross Medical Center, 4Department of Neurosurgery, Japanese Red Cross Medical Center
BULLETIN of Showa Pharmaceutical University (49) 1-8, 2015.
1Educational and Research Center for Clinical Pharmacy, Showa Pharmaceutical University, 2Department of Pharmacy, Japanese Red Cross Medical Center, 3Department of Hematology, Japanese Red Cross Medical Center, 4Department of Neurosurgery, Japanese Red Cross Medical Center
BULLETIN of Showa Pharmaceutical University (49) 1-8, 2015.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。